SYNCAR-100

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameSYNCAR-100
Drug Alias NameSYNCAR-100
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Circular RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A